BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9131156)

  • 1. The role of platelet-activating factor in the biocompatibility of hemodialysis membranes.
    Tetta C; Haeffner-Cavaillon N; Navino C; David S; Franceschi C; Mariano F; Camussi G
    Adv Exp Med Biol; 1996; 416():243-8. PubMed ID: 9131156
    [No Abstract]   [Full Text] [Related]  

  • 2. The role of platelet-activating factor in the haemoincompatibility of haemodialytic treatments.
    Tetta C; Wratten M; Cristol JP; Tarchini R; Bosc JY; Canaud B; Camussi G
    Int J Artif Organs; 1998 Nov; 21(11):693-8. PubMed ID: 9894743
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of PAF and leukotrienes in bioincompatibility of cuprophane membranes in hemodialysis.
    Kabasakal C; Mir S; Gousseinov A; Cura A; Betin N; Coker I
    Turk J Pediatr; 1998; 40(3):413-20. PubMed ID: 9763906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of platelet activating factor in hemodialysis.
    Tetta C; David S; Biancone L; Canino F; Cambi V; Camussi G
    Kidney Int Suppl; 1993 Jan; 39():S154-7. PubMed ID: 8468919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms and kinetics of the synthesis and release of platelet-activating factor (PAF) by polyacrylonitrile membranes.
    Guastoni C; Tetta C; Hoenich NA; Gervasio R; Sereni L; Tessore E; Wratten ML; Civati G
    Clin Nephrol; 1996 Aug; 46(2):132-8. PubMed ID: 8869791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet-neutrophil interactions during hemodialysis: a proposed biocompatibility approach.
    Stuard S; Bonomini M; Settefrati N; Albertazzi A
    Int J Artif Organs; 1998 Feb; 21(2):75-82. PubMed ID: 9569128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biocompatibility aspects of chronic hemodialysis and their clinical relevance.
    Wauters JP
    Clin Nephrol; 1995 Nov; 44 Suppl 1():S19-23. PubMed ID: 8608656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodialysis membrane biocompatibility--does it matter?
    Jacobson SH
    Scand J Urol Nephrol; 1999 Apr; 33(2):83-8. PubMed ID: 10360446
    [No Abstract]   [Full Text] [Related]  

  • 9. Efficiency and biocompatibility of membranes.
    Churchill DN
    Contrib Nephrol; 1995; 113():60-71. PubMed ID: 7712723
    [No Abstract]   [Full Text] [Related]  

  • 10. Biocompatibility and the clinical choice of dialysis membranes.
    Mujais SK; Ivanovich P; Bereza LA; Vidovich M
    Contrib Nephrol; 1995; 113():101-9. PubMed ID: 7712716
    [No Abstract]   [Full Text] [Related]  

  • 11. [Does the biocompatibility of the hemodialysis membrane influence the prognosis of acute renal insufficiency?].
    Tielemans C; Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL
    Nephrologie; 1998; 19(2):89-91. PubMed ID: 9592779
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leukocyte, platelet and endothelial activation in patients with acute renal failure treated by intermittent hemodialysis.
    de Sá HM; Freitas LA; Alves VC; Garção MF; Rosa MA; Marques AA
    Am J Nephrol; 2001; 21(4):264-73. PubMed ID: 11509797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biocompatibility of haemodialysis membranes: it matters in acute renal failure.
    Krediet RT
    Neth J Med; 1995 Nov; 47(5):205-7. PubMed ID: 8544890
    [No Abstract]   [Full Text] [Related]  

  • 14. Biocompatibility of the polyamide membranes.
    Deppisch R; Betz M; Hänsch GM; Rauterberg EW; Ritz E
    Contrib Nephrol; 1992; 96():26-46. PubMed ID: 1740049
    [No Abstract]   [Full Text] [Related]  

  • 15. The role of dialyzer biocompatibility in acute renal failure.
    Vanholder R; De Vriese A; Lameire N
    Blood Purif; 2000; 18(1):1-12. PubMed ID: 10686437
    [No Abstract]   [Full Text] [Related]  

  • 16. Section III. Biocompatibility.
    European Best Practice Guidelines Expert Group on Hemodialysis, European Renal Association
    Nephrol Dial Transplant; 2002; 17 Suppl 7():32-44. PubMed ID: 12386216
    [No Abstract]   [Full Text] [Related]  

  • 17. Biocompatibility and acute renal failure.
    Kanagasundaram NS; Sakiewicz PG; Liangos O; Paganini EP
    Lancet; 2000 Jan; 355(9200):313. PubMed ID: 10675091
    [No Abstract]   [Full Text] [Related]  

  • 18. Biocompatibility and acute renal failure.
    Hoste E; Decruyenaere J; Colardyn F
    Lancet; 2000 Jan; 355(9200):312-3; author reply 313-4. PubMed ID: 10675090
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of polyethersulfone highflux hemodialysis membrane in vitro and in vivo.
    Su BH; Fu P; Li Q; Tao Y; Li Z; Zao HS; Zhao CS
    J Mater Sci Mater Med; 2008 Feb; 19(2):745-51. PubMed ID: 17619985
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biocompatibility and acute renal failure.
    Star RA; Kimmel PL
    Lancet; 2000 Jan; 355(9200):314. PubMed ID: 10675092
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.